29,482 press releases indexed under finance.
BALLERUP, Denmark, September 18, 2026--LEO Pharma announces FDA acceptance of dersimelagon NDA with Priority Review and closes acquisition from Tanabe Pharma
HAIFA, Israel, Sept. 18, 2026 /PRNewswire/ -- Elbit Systems Ltd. (NASDAQ: ESLT) (TASE: ESLT) ("Elbit Systems" or the "Company") announced today that it has filed a shelf prospectus with the Israel Securities Authority and the Tel Aviv Stock Exchange (the "Shelf Prospectus"). The Shelf...
PARIS, September 18, 2026-- TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) has entered into a partnership agreement with Global Infrastructure Partners (GIP), a part of BlackRock, relating to TotalEnergies’ interests in some oil & gas infrastructure assets in Africa. In exchange for a US$1.8 billion capital contribution, TotalEnergies will pay GIP a throughput-based tariff over a period of up to 15 years.
will announce its full-year results on Tuesday 22 September 2026
Please see below information about transactions made under the buy-back programme for Equinor ASA (OSE:EQNR, NYSE:EQNR) for shares to be used in the share-based incentive programmes for employees and management.
Nedenfor følger informasjon om transaksjoner knyttet til tilbakekjøpsprogrammet for Equinor ASA (OSE:EQNR, NYSE:EQNR) til bruk i aksjebaserte insentivprogrammer for ansatte og ledelse.
TORONTO et PERTH, Australie-Occidentale, 18 sept. 2026 (GLOBE NEWSWIRE) -- Cygnus Metals Limited (ASX: CY5, TSXV: CYG, OTCQB: CYGGF) ( Cygnus ou la Société ) fournit la mise à jour suivante relativement à la transaction proposée en vertu de laquelle Central Asia Metals PLC (AIM: CAML) ( CAML ) fera l'acquisition de 100 % des actions de Cygnus aux termes d'un plan d'arrangement conformément à la partie 5.1 de la Loi sur les sociétés de 2001 (Cth) ( plan d'arrangement ).
OSAKA, Japan & CAMBRIDGE, Mass., September 18, 2026--Takeda (TSE:4502/NYSE: TAK) announced that it has awarded a total of USD 22.2 million to four new Global Corporate Social Responsibility (CSR) partners as part of the company’s ongoing commitment to supporting climate-resilient health systems in low- and middle-income countries around the world and aligned with the company’s purpose of better health for people, brighter future for the world. As climate change, extreme weather events and shifti
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / September 18, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Aardvark Therapeutics, Inc. (NASDAQ:AARD) securities. If you suffered a loss on your Aardvark Therapeutics, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Aardvark Therapeutics, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: This lawsuit is on behalf of a class ..
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / September 18, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Aardvark Therapeutics, Inc. (NASDAQ:AARD) securities. If you suffered a loss on your Aardvark Therapeutics, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Aardvark Therapeutics, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: This lawsuit is on behalf of a class ..
Bolt prévoit de déployer au moins 25 000 véhicules autonomes Lucid dans des grandes villes européennes, équipés de la technologie NVIDIA Hyperion NEWARK, Californie, et TALLINN, Estonie, 18 septembre 2026 /PRNewswire/ -- Lucid Group, Inc. (NASDAQ : LCID), constructeur de véhicules et de...
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / September 18, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Aardvark Therapeutics, Inc. (NASDAQ:AARD) securities. If you suffered a loss on your Aardvark Therapeutics, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Aardvark Therapeutics, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: This lawsuit is on behalf of a class ..